Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

NCT01006031 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

NETWORK

Sponsor class

Conditions

Liver Cirrhosis
Hepatitis C Virus
HIV Infection

Interventions

DRUG: Pegylated interferon alfa-2a and Ribavirin

Sponsor

Sociedad Andaluza de Enfermedades Infecciosas